Track Prenetics Global Limited Class A Ordinary Share — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Prenetics Global Limited Class A Ordinary Share PRE Open Prenetics Global Limited Class A Ordinary Share in new tab

14.54 USD
EPS
-2.46
P/B
1.60
ROE
-31.79
Beta
0.15
Key Metrics
Earnings dateSept. 11, 2026
EPS-2.46
Book Value10.89
Price to Book1.60
Debt/Equity1.01
% Insiders13.825%
Growth
Revenue Growth2.49%
Estimates
Forward P/E-25.54
Forward EPS-0.68

DCF Valuation

Tweak assumptions to recompute fair value for Prenetics Global Limited Class A Ordinary Share (PRE)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Prenetics Global Limited Class A Ordinary Share Analysis (PRE)

Hong Kong Health Care Stock

Is Prenetics Global Limited Class A Ordinary Share a good investment? Prenetics Global Limited Class A Ordinary Share (PRE) is currently trading at 14.54 USD.

Earnings Schedule: Prenetics Global Limited Class A Ordinary Share is expected to release its next earnings report on Sept. 11, 2026. The market consensus estimate for Forward EPS is -0.68.

Investor FAQ

Does Prenetics Global Limited Class A Ordinary Share pay a dividend?

No, it does not currently pay a dividend.

What asset class is Prenetics Global Limited Class A Ordinary Share?

Prenetics Global Limited Class A Ordinary Share is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Sept. 11, 2026. The company currently has a trailing EPS of -2.46.

Company Profile

Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion